Tenax Therapeutics (TENX) Operating Margin (2016)
Historic Operating Margin for Tenax Therapeutics (TENX) over the last 4 years, with Q2 2013 value amounting to 4444.87%.
- Tenax Therapeutics' Operating Margin fell 189352200.0% to 4444.87% in Q2 2013 from the same period last year, while for Dec 2015 it was 3771409.64%, marking a year-over-year change of. This contributed to the annual value of 84756.52% for FY2024, which is 504481900.0% up from last year.
- According to the latest figures from Q2 2013, Tenax Therapeutics' Operating Margin is 4444.87%, which was down 189352200.0% from 715.64% recorded in Q1 2013.
- Over the past 5 years, Tenax Therapeutics' Operating Margin peaked at 14490.35% during Q2 2012, and registered a low of 250680.02% during Q3 2010.
- In the last 4 years, Tenax Therapeutics' Operating Margin had a median value of 665.7% in 2012 and averaged 19265.68%.
- As far as peak fluctuations go, Tenax Therapeutics' Operating Margin soared by 2000000000bps in 2011, and later plummeted by -189352200bps in 2013.
- Tenax Therapeutics' Operating Margin (Quarter) stood at 7582.16% in 2010, then crashed by -128bps to 2158.73% in 2011, then skyrocketed by 94bps to 132.62% in 2012, then crashed by -3251bps to 4444.87% in 2013.
- Its Operating Margin stands at 4444.87% for Q2 2013, versus 715.64% for Q1 2013 and 132.62% for Q4 2012.